Iodosorb wound dressing is a cadexomer iodine-based treatment designed to manage chronic and acute wounds by absorbing exudate, reducing bacteria, and supporting a moist healing environment. Iodosorb products are commonly used on venous leg ulcers, diabetic foot ulcers, and pressure injuries where infection control is a priority.

Apply Iodosorb directly to the wound bed, ensuring the cadexomer iodine makes full contact with the wound surface before covering with a secondary dressing. Change Iodosorb when the dressing turns white or gray, which signals that the active iodine has been fully absorbed and the dressing needs replacing.

Iodosorb wound care products are designed for patients and clinicians managing chronic, infected, or heavily exuding wounds that have not responded well to standard dressings. Healthcare providers often recommend Iodosorb for patients with venous leg ulcers, diabetic foot wounds, or pressure ulcers where bacterial bioburden is a concern.

Iodosorb dressing should be changed when it turns white or gray, which typically occurs every one to three days depending on the level of wound exudate. High-exudate wounds may require more frequent changes, while lower-output wounds may allow Iodosorb to remain in place longer before replacement is needed.

Iodosorb wound care products are available in both gel and pad forms, giving clinicians flexibility to match the format to the wound shape and depth. The gel form works well for irregularly shaped or cavity wounds, while Iodosorb pads suit flatter wound surfaces and are easier to handle during dressing changes.

Yes, Iodosorb is considered safe for use on infected and critically colonized wounds when used as directed by a healthcare professional. The cadexomer iodine in Iodosorb releases iodine slowly into the wound, providing antimicrobial action while minimizing the risk of systemic toxicity associated with older iodine-based treatments.

Because Iodosorb combines exudate absorption with sustained antimicrobial release in a single dressing, which reduces the need for additional antimicrobial agents. Iodosorb's cadexomer iodine formula has clinical evidence supporting its effectiveness against biofilm, a key factor in stalled chronic wound healing that many standard dressings do not address.

Yes, Iodosorb is commonly used on diabetic foot ulcers, particularly when the wound shows signs of infection or critical colonization. Clinicians choose Iodosorb for diabetic foot wounds because cadexomer iodine helps reduce bacterial load while managing moisture levels, both of which are critical factors in diabetic wound healing.

Iodosorb uses cadexomer iodine as its active antimicrobial agent, while silver-based dressings rely on ionic silver to reduce bacterial load in wounds. Both are effective antimicrobial options, but Iodosorb may be preferred when patients have sensitivities to silver or when clinical protocols call for an iodine-based approach to biofilm management.

Iodosorb wound dressings should be stored at room temperature in a cool, dry place away from direct sunlight and moisture to maintain product integrity. Always check the expiration date before use, and keep Iodosorb in its original sealed packaging until the dressing is needed to prevent contamination or premature activation.